Perspective: The clinical trial barriers

Liang Liu (), Elaine Lai-Han Leung and Xiaoying Tian
Additional contact information
Liang Liu: Liang Liu is vice-rector at State Key Laboratory for Quality Research in Chinese Medicines, Macau University of Science and Technology, China.
Elaine Lai-Han Leung: Elaine Lai-Han Leung is a researcher at State Key Laboratory for Quality Research in Chinese Medicines, Macau University of Science and Technology, China.
Xiaoying Tian: Xiaoying Tian is a researcher at the School of Chinese Medicine, Hong Kong Baptist University.

Nature, 2011, vol. 480, issue 7378, S100-S100

Abstract: To investigate traditional Asian medicines properly, we need to rethink the way they are tested, say Liang Liu, Elaine Lai-Han Leung and Xiaoying Tian.

Date: 2011
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/480S100a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:480:y:2011:i:7378:d:10.1038_480s100a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/480S100a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().